Persistent Asset Partners LTD Reviva Pharmaceuticals Holdings, Inc. Transaction History
Persistent Asset Partners LTD
- $121 Billion
- Q4 2024
A detailed history of Persistent Asset Partners LTD transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 161,170 shares of RVPH stock, worth $257,872. This represents 0.25% of its overall portfolio holdings.
Number of Shares
161,170Holding current value
$257,872% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding RVPH
# of Institutions
51Shares Held
7.83MCall Options Held
628KPut Options Held
338K-
Israel Englander Millennium Management LLC | New York, Ny1.8MShares$2.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.22 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.36MShares$2.18 Million0.03% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.06MShares$1.69 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT514KShares$822,8360.13% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $32.7M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...